GFM
INBX icon

GF Fund Management’s Inhibrx INBX Stock Holding History

GF Fund Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.6K Sell
312
-14
-4% -$1.4K ﹤0.01% 448
2026
Q1 		$21.9K Buy
326
+41
+14% +$3.04K ﹤0.01% 490
2025
Q4 		$22.5K Sell
285
-22
-7% -$1.5K ﹤0.01% 492
2025
Q3 		$10.3K Sell
307
-52
-14% -$1.28K ﹤0.01% 554
2025
Q2 		$5.12K Hold
359
– – ﹤0.01% 623
2025
Q1 		$5.02K Buy
359
+55
+18% +$747 ﹤0.01% 624
2024
Q4 		$4.68K Buy
+304
New +$4.63K ﹤0.01% 612

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GF Fund Management's INBX Position: Q2 2026 in Review

GF Fund Management reduced its Inhibrx (INBX) stake by 4.3% in Q2 2026, selling an estimated $1.4K and leaving 312 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

GF Fund Management first reported a position in INBX in Q4 2024 and has held it in 7 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • GF Fund Management held 312 shares of Inhibrx worth $29.6K as of Q2 2026.
  • GF Fund Management sold 14 Inhibrx shares in Q2 2026, an estimated $1.4K.
  • Inhibrx made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #448 holding.
  • GF Fund Management first reported a position in Inhibrx in Q4 2024 and has held it in 7 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.